He is currently a Co-Leader of the endTB project at Partners In Health, which is a $60.4 million UNITAID-funded project that aims to find shorter, less toxic, and more effective treatments for MDR-TB, through increased access to new drugs, a clinical trial, and advocacy at the country and global level. endTB is expected to have significant global impact, by changing WHO policy around the treatment of MDR-TB.